Tredese F, Maggino T, Salvagno L, Marchesoni D, Chizzolini M, Pattaro R F
Eur J Gynaecol Oncol. 1985;6(2):136-8.
A comparison between plasma lipid-bound sialic acid (LBSA) and carcinoembryonic antigen (CEA) in gynaecologic cancer patients has been performed. The LBSA level appears more specific then the CEA, especially for ovarian cancer. This finding has promoted a longitudinal study to show if LBSA test may prove a reliable marker of disease in ovarian cancer patients.
已对妇科癌症患者的血浆脂质结合唾液酸（LBSA）和癌胚抗原（CEA）进行了比较。LBSA水平似乎比CEA更具特异性，尤其是对于卵巢癌。这一发现推动了一项纵向研究，以确定LBSA检测是否可能被证明是卵巢癌患者疾病的可靠标志物。
